Epperly Melissa B,
CIK 1807359 · Chief Financial Officer · last filed 2026-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.19M
Companies
5
Total Filings
49
Lifetime Open-Market Net
-$4.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 16,474 | $30.04 | $494.9K | -$1.20M | 16 | 2026-04-21 |
| NAUT | Director | — | $2.24 | — | $0 | 4 | 2025-06-25 |
| ZNTL | Chief Financial Officer | 451,449 | $3.75 | $1.69M | -$3.15M | 23 | 2024-02-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 1,280 | $2.75 | $3.5K | $0 | 2 | 2023-07-06 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
Recent Filings · Page 4 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-15 | Kinnate Biopharma Inc. (KNTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | ZNTL | Sell (S) | −17,080 | -$855.5K | EDGAR |
| 2022-02-23 | ZNTL | Sell (S) | −1,913 | -$93.9K | EDGAR |
| 2022-02-14 | ZNTL | Grant (A) | +16,405 | $0 | EDGAR |
| 2021-10-04 | ZNTL | Tax (F) | −17,080 | -$1.15M | EDGAR |
| 2021-08-20 | ZNTL | Buy (P) | +9,611 | $499.7K | EDGAR |
| 2021-07-06 | ZNTL | Sell (S) | −3,083 | -$158.1K | EDGAR |
| 2021-06-14 | Kinnate Biopharma Inc. (KNTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | ZNTL | Sell (S) | −3,083 | -$166.6K | EDGAR |
| 2021-05-05 | ZNTL | Sell (S) | −3,083 | -$182.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.